Thalidomide-O-amido-propoxy-PEG2-C3-amine TFA salt CAS:1799711-29-7 is a type of small molecule drug that is used in the treatment of certain types of cancer and inflammatory diseases. It is composed of several functional groups, including a thalidomide group, a PEG spacer, an amido-propoxy group, a C3-amine group, and a trifluoroacetic acid (TFA) salt.
Thalidomide is a type of immunomodulatory drug that has been shown to be effective in treating certain types of cancer and inflammatory diseases. The PEG spacer in Thalidomide-O-amido-propoxy-PEG2-C3-amine TFA salt is used to improve the solubility and stability of the drug in solution, allowing it to be more easily administered to patients. The amido-propoxy group and C3-amine group are important for the chemical reactivity and solubility of the compound, while the TFA salt helps to improve the stability of the drug in solution.
In terms of its mechanism of action, Thalidomide-O-amido-propoxy-PEG2-C3-amine TFA salt works by modulating the activity of certain immune cells in the body, particularly T cells and natural killer cells. By enhancing the activity of these cells, Thalidomide-O-amido-propoxy-PEG2-C3-amine TFA salt can help to boost the body’s immune response to cancer cells and reduce inflammation, leading to improved outcomes for patients with cancer and inflammatory diseases.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
